Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Kim, Changyoun, Ho, Dong-Hwan, Suk, Ji-Eun, You, Sungyong, Michael, Sarah, Kang, Junghee, Joong Lee, Sung, Masliah, Eliezer +3 more·2013·Nature Communications

Cited by (863)

Items 201–300 of 863

  1. Interventions for age-related diseases: Shifting the paradigm
    Inês Figueira, Adelaide Maria Afonso Fernandes, Aleksandra Mladenović, Andres Joaquin Lopez-Contreras, Catarina Martins Henriques, Colin Selman, Elisabete B. Ferreiro, Efstathios S. Gonos, José Luís Trejo, Juhi Misra et al. · 2016 · Mechanisms of Ageing and Development
  2. Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death
    Liuke Sun, Ruifang Shen, Sandeep Kumar Agnihotri, Yun Chen, Zhiwei Huang, Hansruedi Büeler · 2018 · Scientific Reports
  3. Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease
    Kumaran, Ravindran, Cookson, Mark R. · 2015 · Human Molecular Genetics
  4. Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
    Sonia George, Patrik Brundin · 2015 · Journal of Parkinson s Disease
  5. Bacterium-Like Particles for Efficient Immune Stimulation of Existing Vaccines and New Subunit Vaccines in Mucosal Applications
    Natalija Budimir, Bert Jan Haijema, Kees J. Leenhouts · 2013 · Frontiers in Immunology
  6. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy
    Phillip A. Engen, Hemraj B. Dodiya, Ankur D Naqib, Christopher B. Forsyth, Stefan J. Green, Robin M. Voigt, Jeffrey H. Kordower, Ece Mutlu, Kathleen M. Shannon, Ali Keshavarzian · 2017 · Journal of Parkinson s Disease
  7. Nurr1: A vital participant in the TLR4-NF-κB signal pathway stimulated by α-synuclein in BV-2 cells
    Qian-Hang Shao, Wen-Fen Yan, Zhao Zhang, Kaili Ma, Shan-Ying Peng, Yingli Cao, Yu‐He Yuan, Nai‐Hong Chen · 2018 · Neuropharmacology
  8. Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
    Nelson de Oliveira Manzanza, Lucia Sedlackova, Raj N. Kalaria · 2021 · Frontiers in Aging Neuroscience
  9. Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
    Shuanglong Yi, Lin-Fang Wang, Honglei Wang, M. Ho, Shi-Ping Zhang · 2022 · International Journal of Molecular Sciences
  10. Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation
    Sylvia Torres-Odio, Jana Key, Hans-Hermann Hoepken, Júlia Canet-Pons, Lucie Valek, Bastian Roller, Michael J. Walter, Blas Morales-Gordo, David Meierhofer, Patrick N. Harter et al. · 2017 · Journal of Neuroinflammation
  11. Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
    Amanda N. Sacino, Mieu Brooks, Nicholas H. McGarvey, Alex B. McKinney, Michael A Thomas, Yona Levites, Yong Ran, Todd Eliot Golde, Benoit I. Giasson · 2013 · Acta Neuropathologica Communications
  12. Neurodegenerative diseases: The immunological perspective
    Monica Molteni, Carlo Rossetti · 2017 · Journal of Neuroimmunology
  13. Bifidobacterium pseudocatenulatum CECT 7765 ameliorates neuroendocrine alterations associated with an exaggerated stress response and anhedonia in obese mice
    Agusti, Ana, Moya-Pérez, A., Campillo, I., Montserrat-de la Paz, S., Cerrudo, V., Perez-Villalba, A., Sanz, Yolanda · 2018 · Molecular Neurobiology
  14. Senescent Microglia: The Key to the Ageing Brain?
    Greenwood, Eleanor K., Brown, David R. · 2021 · International Journal of Molecular Sciences
  15. Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
    Marie-Laure Arotçarena, Margaux Teil, Benjamin Dehay · 2019 · Cells
  16. Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases
    Jagdeep K. Sandhu, Marianna Kulka · 2021 · International Journal of Molecular Sciences
  17. Interaction of RAGE with α-synuclein fibrils mediates inflammatory response of microglia
    Houfang Long, Shengnan Zhang, Shuyi Zeng, Yilun Tong, Jun Liu, Cong Liu, Dan Li · 2022 · Cell Reports
  18. Inflammasome assembly in neurodegenerative diseases
    Singh, Jagjit, Habean, Maria L., Panicker, Nikhil · 2023 · Trends in Neurosciences
  19. A cell culture model for monitoring α-synuclein cell-to-cell transfer
    Juan F. Reyes, Tomas T. Olsson, Jennifer T. Lamberts, Michael J. Devine, Tilo Kunath, Patrik Brundin · 2014 · Neurobiology of Disease
  20. Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
    Tuuli-Maria Sonninen, Gundars Goldsteins, Nihay Laham-Karam, Jari Koıstınaho, Šárka Lehtonen · 2020 · Cells
  21. Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder
    Kristine Farmen, Sara Konstantin Nissen, Morten Gersel Stokholm, Álex Iranzo, Karen Østergaard, Mónica Serradell, Marit Otto, Kristina Bacher Svendsen, Alícia Garrido, Dolores Vilas et al. · 2021 · Proceedings of the National Academy of Sciences
  22. An Update on Toll-like Receptor 2, Its Function and Dimerization in Pro- and Anti-Inflammatory Processes
    Katrin Colleselli, Anna Stierschneider, Christoph Wiesner · 2023 · International Journal of Molecular Sciences
  23. Studying neurodegenerative diseases in culture models
    Johannes C. M. Schlachetzki, Soraya Wilke Saliba, Antônio Carlos Pinheiro de Oliveira · 2013 · Brazilian Journal of Psychiatry
  24. A Decade of Research on TLR2 Discovering Its Pivotal Role in Glial Activation and Neuroinflammation in Neurodegenerative Diseases
    Jin Hee Hayward, Sung Joong Lee · 2014 · Experimental Neurobiology
  25. LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies
    Kim, Changyoun, Beilina, Alexandria, Smith, Nathan, Li, Yan, Kim, Minhyung, Kumaran, Ravindran, Kaganovich, Alice, Mamais, Adamantios, Adame, Anthony, Iba, Michiyo et al. · 2020 · Science Translational Medicine
  26. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
    Marco Bisaglia, Roberta Filograna, Mariano Beltramini, Luigi Bubacco · 2014 · Ageing Research Reviews
  27. Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity
    Sorrentino, Zachary A., Brooks, Mieu M.T., Hudson, Vincent, Rutherford, Nicola J., Golde, Todd E., Giasson, Benoit I., Chakrabarty, Paramita · 2017 · Molecular Neurodegeneration
  28. Microbiome, Parkinson’s Disease and Molecular Mimicry
    Fabiana Miraglia, Emanuela Colla · 2019 · Cells
  29. Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
    Margaux Teil, Marie-Laure Arotçarena, Emilie Faggiani, Florent Laferrière, Erwan Bézard, Benjamin Dehay · 2020 · Biomolecules
  30. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease
    Antonella Cardinale, Valeria Calabrese, Antonio de Iure, Barbara Picconi · 2021 · International Journal of Molecular Sciences
  31. Viable Neuronopathic Gaucher Disease Model in Medaka (Oryzias latipes) Displays Axonal Accumulation of Alpha-Synuclein
    Norihito Uemura, Masato Koike, Satoshi Ansai, Masato Kinoshita, Tomoko Ishikawa‐Fujiwara, Hideaki Matsui, Kiyoshi Naruse, Naoaki Sakamoto, Yasuo Uchiyama, Takeshi Todo et al. · 2015 · PLoS Genetics
  32. Release and uptake of pathologic alpha-synuclein
    Veselin Grozdanov, Karin M. Danzer · 2018 · Cell and Tissue Research
  33. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease
    Liang Ma, Chen Yang, Xia Zhang, Yang Li, Shun Li Wang, Ling Zheng, Kun Huang · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  34. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
    Yuanyuan Li, Mengyue Niu, Aonan Zhao, Wenyan Kang, Zhichun Chen, Ningdi Luo, Liche Zhou, Xiongwei Zhu, Liming Lu, Jun Liu · 2019 · Journal of Neuroinflammation
  35. Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration
    Chen, Shih-Heng, Oyarzabal, Esteban A, Hong, Jau-Shyong · 2016 · Current Opinion in Pharmacology
  36. Mechanisms of alpha-synuclein toxicity: An update and outlook
    Inês Caldeira Brás, Mary Xylaki, Tiago F. Outeiro · 2019 · Progress in brain research
  37. Animal models of brain-first and body-first Parkinson's disease
    Nathalie Van Den Berge, Ayşe Ulusoy · 2021 · Neurobiology of Disease
  38. Alpha-synuclein fibrils recruit TBK1 and OPTN to lysosomal damage sites and induce autophagy in microglial cells
    Claudio Bussi, Javier María Peralta Ramos, Daniela Soledad Arroyo, José Ignacio Gallea, Paolo Ronchi, Androniki Kolovou, Ji M. Wang, Oliver Florey, M. Soledad Celej, Yannick Schwab et al. · 2018 · Journal of Cell Science
  39. Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis
    Jennifer T. Lamberts, Erin N. Hildebrandt, Patrik Brundin · 2014 · Neurobiology of Disease
  40. Targeting Inflammasomes to Treat Neurological Diseases
    Jan D. Lünemann, Sunny Malhotra, Mari L. Shinohara, Xavier Montalbán, Manuel Comabella · 2021 · Annals of Neurology
  41. α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function
    Wei‐Li Kuan, Neal K. Bennett, Xiaoling He, Jeremy N. Skepper, Nataly Martynyuk, Ruwani Wijeyekoon, Prabhas V. Moghe, Caroline H. Williams‐Gray, Roger A. Barker · 2016 · Experimental Neurology
  42. Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease
    Garcia, Pierre, Jürgens‐Wemheuer, Wiebke, Uriarte Huarte, Oihane, Michelucci, Alessandro, Masuch, Annette, Brioschi, Simone, Weihofen, Andreas, Koncina, Eric, Coowar, Djalil, Heurtaux, Tony et al. · 2022 · Glia
  43. Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
    Violetta Refolo, Nadia Stefanova · 2019 · Frontiers in Cellular Neuroscience
  44. Are exosomes the vehicle for protein aggregate propagation in neurodegenerative diseases?
    Yoon-Ju Lim, Seung-Jae Lee · 2017 · Acta Neuropathologica Communications
  45. Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils
    Isabella Russo, Alice Kaganovich, Jinhui Ding, Natalie Landeck, Adamantios Mamais, Tatiana Varanita, Alice Biosa, Isabella Tessari, Luigi Bubacco, Elisa Greggio et al. · 2019 · Neurobiology of Disease
  46. Neuroinflammation in Synucleinopathies
    Somin Lim, Yewon Chun, Jun Sung Lee, Seung‐Jae Lee · 2016 · Brain Pathology
  47. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
    Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpędek‐Kamińska, Ireneusz Majsterek · 2023 · International Journal of Molecular Sciences
  48. Regulation of the neurodegenerative process associated to Parkinson's disease by CD4+ T-cells
    González, Hugo, Contreras, Francisco, Pacheco, Rodrigo · 2015 · Journal of Neuroimmune Pharmacology
  49. Antibodies and protein misfolding: From structural research tools to therapeutic strategies
    Erwin De Genst, Anne C. Messer, Christopher Martin Dobson · 2014 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  50. Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions
    Seiji Kaji, Takakuni Maki, Tomoyuki Ishimoto, Hodaka Yamakado, Ryōsuke Takahashi · 2020 · Translational Neurodegeneration
  51. New hope for Parkinson’s disease treatment: Targeting gut microbiota
    Fan, Hong‐Xia, Sheng, Shuo, Zhang, Feng · 2022 · CNS Neuroscience & Therapeutics
  52. Bent out of shape: α‐Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease
    Esteban Luna, Kelvin C. Luk · 2015 · FEBS Letters
  53. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson’s disease-like pathology in neurons and glia
    Martin T. Henrich, Fanni F. Geibl, Bolam Lee, Wei‐Hua Chiu, James B. Koprich, Jonathan M. Brotchie, Lars Timmermann, Niels Decher, Lina A. Matschke, Wolfgang Hermann Oertel · 2018 · Acta Neuropathologica Communications
  54. The role of microglia in the development of neurodegeneration
    Aigul R. Saitgareeva, Kirill Vladimirovich Bulygin, Гареев Ильгиз Фанилевич, Ozal Beylerli, Л.Р. Ахмадеева · 2020 · Neurological Sciences
  55. Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
    Shinichi Takahashi, Kyoko Mashima · 2022 · Antioxidants
  56. Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
    Elvira Valera, Michael Mante, Scott Anderson, Edward M. Rockenstein, Eliezer Masliah · 2015 · Journal of Neuroinflammation
  57. Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration
    Russell L. Blaylock · 2017 · Surgical Neurology International
  58. Chemical modification of pro-inflammatory proteins by peroxynitrite increases activation of TLR4 and NF-κB: Implications for the health effects of air pollution and oxidative stress
    Kira Ziegler, Anna Theresa Kunert, Kathrin Reinmuth-Selzle, Anna Lena Leifke, Darius Widera, Michael G. Weller, Detlef Schuppan, Janine Fröhlich‐Nowoisky, Kurt Lucas, Ulrich Pöschl · 2020 · Redox Biology
  59. The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates
    Sandesh Neupane, Elena De Cecco, Adriano Aguzzi · 2022 · Journal of Molecular Biology
  60. The role of macropinocytosis in the propagation of protein aggregation associated with neurodegenerative diseases
    Rafaa Zeineddine, Justin J. Yerbury · 2015 · Frontiers in Physiology
  61. Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
    Ana Carolina Buzzo Stefanini, Bianca Rodrigues da Cunha, Tiago Henrique, Eloíza H. Tajara · 2015 · Disease Markers
  62. Emerging Immunotherapies for Parkinson Disease
    Zella, Samis M. A., Metzdorf, Judith, Ciftci, Emine, Ostendorf, Friederike, Muhlack, Siegfried, Gold, Ralf, Tönges, Lars · 2019 · Neurology and Therapy
  63. Neuroinflammation in Parkinson’s Disease: Triggers, Mechanisms, and Immunotherapies
    Tai Wang, Changhe Shi, Haiyang Luo, Huimin Zheng, Liyuan Fan, Mibo Tang, Yun Su, Jing Yang, Chengyuan Mao, Yuming Xu · 2021 · The Neuroscientist
  64. Senescence and impaired DNA damage responses in alpha-synucleinopathy models
    Ye-Seul Yoon, Jueng Soo You, Tae-Kyung Kim, Woo Jung Ahn, Myoung Jun Kim, Keun Hong Son, Diadem Ricarte, Darlene Mae Ortiz, Seung‐Jae Lee, He-Jin Lee · 2022 · Experimental & Molecular Medicine
  65. Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson’s disease
    Yunseon Yang, Jae‐Jin Song, Yu Ree Choi, Seong Hoon Kim, Min‐Jong Seok, Noviana Wulansari, Wahyu Handoko Wibowo Darsono, Oh‐Chan Kwon, Mi‐Yoon Chang, Sang Myun Park et al. · 2022 · Proceedings of the National Academy of Sciences
  66. Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies
    Ian F. Caplan, Kathleen A. Maguire‐Zeiss · 2018 · Frontiers in Pharmacology
  67. Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
    Tatsunori Maekawa, Toshikuni Sasaoka, Sadahiro Azuma, Takafumi Ichikawa, Heather L. Melrose, Matthew James Farrer, Fumiya Obata · 2016 · BMC Neuroscience
  68. The multiple roles of exosomes in Parkinson's disease: an overview
    Chiara Porro, Maria Antonietta Panaro, Dario Domenico Lofrumento, Elona Hasalla, Teresa Trotta · 2019 · Immunopharmacology and Immunotoxicology
  69. Towards PET imaging of the dynamic phenotypes of microglia
    Wissam Beaino, Bieneke Janssen, Daniëlle J. Vugts, Helga E. de Vries, Albert D. Windhorst · 2021 · Clinical & Experimental Immunology
  70. Reformulating Pro-Oxidant Microglia in Neurodegeneration
    Juan García‐Revilla, Isabel María Alonso-Bellido, Miguel Ángel Burguillos, Antonio J. Herrera, Ana M. Espinosa‐Oliva, Rocío Ruiz, Luis Cruz-Hernández, Irene García-Domínguez, María Angustias Roca-Ceballos, Marti Santiago et al. · 2019 · Journal of Clinical Medicine
  71. Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates
    Acuña, Leonardo, Hamadat, Sabah, Corbalán, Natalia S., González-Lizárraga, Florencia, dos-Santos-Pereira, Mauricio, Rocca, Jérémy, Sepúlveda Díaz, Julia, Del-Bel, Elaine, Papy-García, Dulce, Chehín, Rosana N. et al. · 2019 · Cells
  72. Palmitic Acid and Oleic Acid Differently Modulate TLR2-Mediated Inflammatory Responses in Microglia and Macrophages
    Howe, Anne-Marie, Burke, Sinéad, O’Reilly, Marcella E., McGillicuddy, Fiona C., Costello, Derek A. · 2022 · Molecular Neurobiology
  73. Inflammation in dementia with Lewy bodies
    Jay Amin, Daniel Erskine, Paul C. Donaghy, Ajenthan Surendranathan, Peter Swann, Amy Kunicki, Delphine Boche, Clive Holmes, Ian Grant McKeith, John Tiernan O'Brien et al. · 2022 · Neurobiology of Disease
  74. MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
    Lu Geng, Wenqing Gao, Hexige Saiyin, Yuanyuan Li, Yu Zeng, Zhifei Zhang, Zuolong Liu, Zuolong Liu, Qiang Gao, Ping An et al. · 2023 · Molecular Neurodegeneration
  75. Essential Oil Constituents as Anti-Inflammatory and Neuroprotective Agents: An Insight through Microglia Modulation
    Nikola M. Stojanović, Pavle J. Randjelović, Maja Simonović, Milica Radić, Stefan Todorović, Myles Corrigan, Andrew Harkin, Fábio Boylan · 2024 · International Journal of Molecular Sciences
  76. Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
    Deirdre B. Hoban, Shelby Shrigley, Bengt Mattsson, Ludivine S. Breger, Ulla Jarl, Tiago Cardoso, Jenny Nelander Wahlestedt, Kelvin C. Luk, Anders Björklund, Malin Parmar · 2020 · Proceedings of the National Academy of Sciences
  77. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson’s disease
    Yanan Zhang, Jing-Kai Fan, Li Gu, Huimin Yang, Shu-Qin Zhan, Hong Zhang · 2021 · Journal of Neuroinflammation
  78. Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
    Miriam Højholt Terkelsen, Ida Hyllen Klæstrup, Victor Schwartz Hvingelby, Johanne Lauritsen, Nicola Pavese, Marina Romero‐Ramos · 2022 · Journal of Parkinson s Disease
  79. Immune mechanisms and shared immune targets in neurodegenerative diseases
    Howard L. Weiner · 2024 · Nature Reviews Neurology
  80. β1-integrin-dependent migration of microglia in response to neuron-released α-synuclein
    Changyoun Kim, Eun-Deok Cho, Hyung-Koo Kim, Sungyong You, He-Jin Lee, Daehee Hwang, Seung‐Jae Lee · 2014 · Experimental & Molecular Medicine
  81. Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases
    Francesco Girolamo, Cristiana Coppola, Doménico Ribatti · 2017 · Brain Behavior and Immunity
  82. Alpha synuclein in hematopoiesis and immunity
    Yu Pei, Robert W. Maitta · 2019 · Heliyon
  83. NRF2 Loss Accentuates Parkinsonian Pathology and Behavioral Dysfunction in Human α-Synuclein Overexpressing Mice
    Annadurai Anandhan, Nhat Nguyen, Arjun Syal, Luke A Dreher, Matthew B. Dodson, Donna D Zhang, Lalitha Madhavan · 2021 · Aging and Disease
  84. Combined Effect of TLR2 Gene Polymorphism and Early Life Stress on the Age at Onset of Bipolar Disorders
    José Oliveira, Bruno Étain, Mohamed Lajnef, Nora Hamdani, Mériem Bennabi, Djaouïda Bengoufa, Aparna Sundaresh, Arij Ben Chaabene, Frank Bellivier, Chantal Henry et al. · 2015 · PLoS ONE
  85. α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease
    Brian J. Spencer, Changyoun Kim, Tania Gonzalez, Alejandro Bisquertt, Christina Patrick, Edward M. Rockenstein, Anthony Adame, Seung‐Jae Lee, Paula Desplats, Eliezer Masliah · 2016 · Human Molecular Genetics
  86. Microglial glutamate release evoked by α‐synuclein aggregates is prevented by dopamine
    Maurício dos Santos Pereira, Leonardo Acuña, Sabah Hamadat, Jérémy Rocca, Florencia González‐Lizárraga, Rosana Nieves Chehín, Julia Elisa Sepulveda-Diaz, Elaine Aparecida Del Bel, Rita Raisman‐Vozari, Patrick Pierre Michel · 2018 · Glia
  87. LRRK2 and the Immune System
    Nicolas L. Dzamko · 2017 · Advances in neurobiology
  88. Microglial Lectins in Health and Neurological Diseases
    Jian Jing Siew, Yijuang Chern · 2018 · Frontiers in Molecular Neuroscience
  89. α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?
    Alice Filippini, Massimo Gennarelli, Isabella Russo · 2019 · Cellular and Molecular Neurobiology
  90. Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection
    Viviane Labrie, Patrik Brundin · 2017 · Journal of Innate Immunity
  91. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease
    Gagandeep Kaur, Tapan Behl, SIMONA GABRIELA BUNGAU, Arun Kumar, Md. Sahab Uddin, Vineet Mehta, Gökhan Zengin, Bijo Mathew, Muhammad Ajmal Shah, Sandeep Arora · 2020 · Current Neuropharmacology
  92. Microglia as therapeutic target in central nervous system disorders
    Oluwaseun Fatoba, Takahide Itokazu, Toshihide Yamashita · 2020 · Journal of Pharmacological Sciences
  93. Microglia Specific Drug Targeting Using Natural Products for the Regulation of Redox Imbalance in Neurodegeneration
    Shashank Kumar Maurya, Neetu Bhattacharya, Suman Mishra, Amit Bhattacharya, Pratibha Banerjee, Sabyasachi Senapati, Rajnikant Mishra · 2021 · Frontiers in Pharmacology
  94. Inflammation promotes synucleinopathy propagation
    Tae-Kyung Kim, Eun-Jin Bae, Byung Chul Jung, Min-Sun Choi, Soo Jean Shin, Sung Jun Park, Jeong Tae Kim, Min Kyo Jung, Ayşe Ulusoy, Mi‐Young Song et al. · 2022 · Experimental & Molecular Medicine
  95. Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials
    Jong Mi Park, Sang Chul Lee, Chorom Ham, Yong Wook Kim · 2023 · Gut Pathogens
  96. Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
    Abid Oueslati, Methodios Ximerakis, Kostas Vekrellis · 2014 · Experimental Neurobiology
  97. Treating Parkinson’s Disease with Antibodies: Previous Studies and Future Directions
    Anne-Marie Castonguay, Claude Gravel, Martin Lévesque · 2020 · Journal of Parkinson s Disease
  98. Emerging Brain‐Pathophysiology‐Mimetic Platforms for Studying Neurodegenerative Diseases: Brain Organoids and Brains‐on‐a‐Chip
    Seokyoung Bang, Songhyun Lee, Nakwon Choi, Hong Nam Kim · 2021 · Advanced Healthcare Materials
  99. The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
    Anamaria Jurcău, Felicia Liana Andronie-Cioară, Carmen Delia Nistor-Cseppento, Nicoleta Pașcalău, Marius Rus, E. Vasca, Maria Carolina Jurcău · 2023 · International Journal of Molecular Sciences
  100. Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates
    Clara Y. Westwell-Roper, Heather C. Denroche, Jan A. Ehses, C. Bruce Verchere · 2016 · Journal of Biological Chemistry